In a historic medical breakthrough, Dr. Vipul Patel, based in Florida, has successfully performed a robot-assisted prostate cancer surgery on a patient located over 7,000 miles away in Angola, Africa.
The patient, 67-year-old Fernando da Silva, was diagnosed with prostate cancer in March. Using transcontinental robotic telesurgery, Dr. Patel remotely carried out a prostatectomy, the removal of cancerous prostate tissue from the Global Robotic Institute at Advent Health in Orlando.
This operation marks the first-ever human clinical trial approved by the U.S. Food and Drug Administration (FDA) to test this cutting-edge remote surgery technology. While robotic-assisted surgeries aren’t new, this is the first time such a procedure has been performed across continents.
Using fiber optic cables for real-time communication and surgical control, Patel reported no perceptible delay in brain-to-robot response. An on-site team remained with the patient in Angola to provide a fail-safe backup.
“We’ve been working on this for two years,” said Patel. “It’s a small step for a surgeon, but a huge leap for health care.”
Patel emphasized the humanitarian and global health potential, particularly for underserved regions and rural areas that lack specialist medical access. He added that similar technology could eventually allow remote emergency surgeries, even inside ambulances.
The success of this operation paves the way for Patel to submit the data to the FDA, aiming to expand the reach of robotic telesurgery worldwide.
